4.7 Article

Signalling pathways involved in ribonuclease-7 expression

Journal

CELLULAR AND MOLECULAR LIFE SCIENCES
Volume 68, Issue 11, Pages 1941-1952

Publisher

SPRINGER BASEL AG
DOI: 10.1007/s00018-010-0540-2

Keywords

Ribonuclease-7 (RNase-7); TGF beta-activated kinase-1 (TAK-1); Nuclear factor kappa B (NF-kappa B); Interleukin-1 beta (IL-1 beta); Mitogen-activated protein kinases (MAPKs)

Funding

  1. British Eye Research Foundation
  2. Royal College of Surgeons of Edinburgh, UK

Ask authors/readers for more resources

Antimicrobial peptides are host defence molecules that play a potential role in preventing infection at the epithelial surfaces. Ribonuclease (RNase)-7 has been shown to possess a broad spectrum of microbicidal activity against various pathogens. Here, we demonstrate that RNase-7 protein is localised to the superficial layers of ocular surface cells and increased in response to interleukin (IL)-1 beta, suggesting an active role during inflammation related to ocular surface infection. Signal transduction pathways involved in RNase-7 expression are unknown. Involvement of transforming growth factor beta-activated kinase-1 (TAK-1) activated nuclear factor kappa B (NF-kappa B) and mitogen-activated protein kinase (MAPK) pathway molecules [c-Jun N-terminal kinase (JNK), extracellular signal-regulated kinase (ERK) and p38] were studied because of their importance in infection and inflammation. Blocking the MAPKs resulted in inhibition of RNase-7 expression in response to IL-1 beta. However, RNase-7 induction by IL-1 beta was not affected by inhibiting the NF-kappa B signalling pathway. In conclusion, our results indicate that RNase-7 expression is specifically mediated via MAPKs but not NF-kappa B signalling pathways.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available